REUTERS - Drugmaker Glenmark Pharmaceuticals Ltd (GLEN.NS) said on Thursday its European unit had launched a generic version of GlaxoSmithKline's (GSK.L) Malarone malaria treatment medicine, its first generic product in Britain.
Glenmark launched the drug after the revocation of Glaxo's patent on Malarone by the High Court in Britain, the Indian company said in a statement, adding the medicine had sales of $28 million in the year ended September.
(Reporting by Sumeet Chatterjee in MUMBAI; editing by Jane Baird)
Trending On Reuters
As India launches an $18 billion plan to spread the information revolution to its provinces, the problems it faces are a holdover from the past - electricity shortages, badly planned, jam-packed cities, and monkeys. Full Article
RBI to leave repo rate on hold next week but cut 25 bps by end-June - Reuters poll Full Article